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Abstract
Background: The Achilles tendon Total Rupture Score was developed by a research group in 2007 in response to
the need for a patient reported outcome measure for this patient population. Beyond this original development
paper, no further validation studies have been published.
Consequently the purpose of this study was to evaluate internal consistency, convergent validity and
responsiveness of this newly developed patient reported outcome measure within patients who have sustained an
isolated acute Achilles tendon rupture.
Methods: Sixty-four eligible patients with an acute rupture of their Achilles tendon completed the Achilles tendon
Total Rupture Score alongside two further patient reported outcome measures (Disability Rating Index and EQ 5D).
These were completed at baseline, six weeks, three months, six months and nine months post injury. The Achilles
tendon Total Rupture Score was evaluated for internal consistency, using Cronbach’s alpha, convergent validity,
through correlation analysis and responsiveness, by analysing floor and ceiling effects and calculating its relative
efficiency in comparison to the Disability Rating Index and EQ 5D scores.
Results: The Achilles tendon Total Rupture Score demonstrated high internal consistency (Cronbachs alpha > 0.8)
and correlated significantly (p < 0.001) with the Disability Rating Index at five time points (pre-injury, six weeks,
three, six and nine months) with correlation coefficients between -0.5 and -0.9. However, the confidence intervals
were wide. Furthermore, the ability of the new score to detect clinically important changes over time
(responsiveness) was shown to be greater than the Disability Rating Index and EQ 5D.
Conclusions: A universally accepted outcome measure is imperative to allow comparisons to be made across
practice. This is the first study to evaluate aspects of validity of this newly developed outcome measure, outside of
the developing centre. The ATRS demonstrated high internal consistency and responsiveness, with limited
convergent validity. This research provides further support for the use of this outcome measure, however further
research is required to advocate its universal use in patients with acute Achilles tendon ruptures. Such areas include
inter-rater reliability and research to determine the minimally clinically important difference between scores.
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Background
Appropriate patient reported outcome measures
(PROMs) are imperative for the evaluation of clinical
practice and research [1]. This is exemplified by the
increasing use of such measures during the last two dec-
ades. Examples of widely used measures within muscu-
loskeletal care include the Victorian Institute of Sports
Assessment questionnaire for patella and achilles tendi-
nopathy [2,3] (VISA and VISA A questionnaires), the
oxford hip and knee scores [4,5], and the Disabilities of
the Arm, Shoulder and Hand score (DASH) [6].
A range of PROMs have also been published specifi-
cally for evaluating patients following a rupture of their
Achilles tendon. Examples of these include the American
Orthopaedic Foot and Ankle Hindfoot score [7], Ther-
mann score [8] and Leppilahti score [9]. However the
development of these measures have predominantly been
based on expert opinion, with a lack of data to support
their validation [10]. In 2007 a research group addressed
this gap through development of a new patient reported
outcome measure, with supporting validation data [10].
This outcome measure was the ‘Achilles tendon Total
Rupture Score’ (ATRS).
The ATRS contains ten items, for which patients are
asked to respond using an 11-grade Likert scale, by tick-
ing one box labelled 0-10. This score of zerois equivalent
to a patient having major limitations/symptoms and a
score of ten is equivalent to a patient having no limita-
tions or symptoms. The score was originally developed
and evaluated in Swedish, using a sample of patients aged
20-70 years with an acute Achilles tendon rupture. The
score evaluates the constructs of ’symptoms and physical
activity’ through five questions addressing symptoms and
five questions addressing physical activity.
The purpose of this study was to evaluate internal
consistency convergent validity and responsiveness of
the ATRS within a UK population of patients who had
sustained an isolated acute Achilles tendon rupture.
Methods
Population identification
Ethical approval for this study was gained. Between
August 2007 and June 2009, 70 patients presenting at the
University hospital with an isolated, acute (< 10 days) mid-
substance rupture of the Achilles tendon were screened.
The diagnosis was established through subjective history
and physical examination to confirm a palpable gap and a
positive Thompson test [11].
Patients with delayed presentation, bilateral ruptures
or other serious lower limb injury were excluded. In
addition, patients who were unable to read the English
language and therefore unable to complete the question-
naires were also excluded. Of the 70 screened patients,
six were excluded. Three were excluded because they
were unable to complete the questionnaires and three
declined to complete the questionnaires.
Following non-operative or operative repair of their
Achilles tendon, all patients were managed using an
immediate weight-bearing protocol. This consisted of
wearing an ankle foot orthoses with inserted heel wedges
for eight weeks, followed by a standardised physical ther-
apy programme.
Questionnaire follow up
All patients were routinely evaluated at baseline, six
weeks, three months, six months and nine months,
using PROMs, which included the ATRS, EQ 5D and
Disability Rating Index (DRI).
In contrast to the ATRS, the DRI is not disease speci-
fic and has been validated for use in a range of ortho-
paedic presentations [12]. It is a self administered
questionnaire with twelve questions regarding common
physical activities, to which patients respond using a 100
mm visual analogue scale. There are two anchor points,
‘without difficulty = 0’ and ‘not at all = 100’. The EQ 5D
was also completed by patients to obtain a global mea-
sure of health [13]. The EQ 5D comprises of five ques-
tions which ask the patient to respond with one of three
options. The combination of these responses results in a
single health index score.
These scores were selected instead of the VISA-A and
Foot and Ankle Orthopaedic Score, which were used by
the developing authors, because the VISA-A is a score
for patients with Achilles tendinopathy not rupture, and
the Foot and Ankle Orthopaedic score has little valida-
tion data in relation to Achilles tendon ruptures [14]
Sample size
There is no agreed optimum method for determining an
appropriate sample size to evaluate aspects of validity
for patient reported outcome measures [15]. However
50 patients have been advocated as the minimum
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requirement by previous studies evaluating aspects of
validity [16]. Our planned case series of 64 patients
would provide sufficient power to investigate important
aspects of validity for the ATRS, and allow for 20% loss
to follow-up.
ATRS analysis plan
Internal consistency was defined as the extent to which
individual items of the ATRS correlate with each other
[10,15]. This is an important aspect of validity because it
determines if all the items within the ATRS are measuring
the same construct. This construct was defined as ‘symp-
toms and physical activity’ by the authors who developed
the ATRS. Internal consistency was evaluated using Cron-
bach’s alpha at each time point within SPSS (v.17.0).
Values between 0.7 and 0.9 are regarded as satisfactory
[17].
Convergent validity was defined as the extent to which
the ATRS correlated with measures consistent with its
theoretically derived construct. This was evaluated by cor-
relating the ATRS with the overall DRI and EQ 5D scores,
and the subdivisions of EQ-5D related to ‘mobility’ and
‘usual activities’and the three subdivisions of the DRI (1:
common basic activities of daily life, 2: more demanding
daily physical activities, 3: work related and more vigorous
activities). Following an assessment of data distribution
using a Shapiro-wilk analysis, the Spearman’s rank correla-
tion coefficient was used within SPSS (v 17.0) at each time
point. The minimum correlation coefficient was defined as
being 0.7 [15].
Responsiveness was defined as the ability of the ATRS to
detect clinically important changes over time [15]. For the
ATRS to be responsive it needs to demonstrate a lack of
‘floor and ceiling’ effects, in that an individual should not
be at the maximum or the minimum value for each time
point. We recorded thatfloor and ceiling effects were
being present if more than 15% of respondents achieved
the lowest or highest possible scores [15]. This was fol-
lowed by a relative efficiency calculation to analyse respon-
siveness of the ATRS versus the EQ5D and DRI according
to Barr et al. [18]. Using this method a score of greater
than 1 would indicate the ATRS was more responsive
than the EQ 5D and DRI and a score less than 1 would
indicate the ATRS to be less responsive than the EQ 5D
and DRI.
Results
Baseline demographics
The baseline demographics of the 64 patients can be
found in Table 1. The sample reflects the broad popula-
tion of patients who sustain this injury. The age range
was from 21-79 years and all of the patients sustained a
complete rupture of the tendon. Nineteen of the 64
patients received operative management. All 64 patients
completed the above three questionnaires at baseline,
which was their pre-injury scores. One patient was lost
to follow-up at six weeks (63 patients, 98%). A further
three were lost to follow-up at the three month time
point (60 patients, 94%) and a further two patients at six
months (58 patients, 91%). Fifty-six patients (88%) com-
pleted the final follow-up questionnaires at nine months.
Descriptive summary
The minimum, maximum, mean and standard deviation
for the ATRS, EQ 5D and DRI at each time point can be
found in Table 2, in addition to the descriptive data for
the separate operative and non-operative groups. This
illustrates that within the ATRS score there is a wider
spread of scores at each time point, in comparison to the
DRI and EQ 5D scores, which will be further discussed in
the final conclusions.
Internal consistency
The internal consistency for the ten items of the ATRS at
each time point was high (Cronbach’s alpha > 0.7). For
pre-injury scores this was 0.98, with a decreasing score of
0.89 at six weeks and three months and increasing to 0.95
and 0.94 at the six and nine month time points (Table 3)
Convergent validity
There were statistically significant (< 0.001) correlations
between the ATRS and DRI scores at each time point,
with correlation coefficients ranging from -0.5 to -0.9,
with the exception of the nine month time point, as
shown in Table 4. Table 4 also shows the 95% confi-
dence intervals for each time point.,
Table 4 illustrates the correlation coefficients for each
construct of the DRI against the ATRS and overall EQ
5D and its two subdivisions against the ATRS at each
time point. In relation to the overall EQ 5D score and
its two sub-divisions the expected size of the correla-
tions did not reach the 0.7 value, pre-defined in the ana-
lysis section. Regarding the three DRI sub-divisions, this
was also not met by the first sub-division of ‘common
basic activities of daily life’. This criteria was only met
within the last time point of the second and third sub-
divisions of ‘more demanding daily physical activities’
and ‘work related and more vigorous activities’.
Table 1 Baseline demographics
Age(Years) 44 (12)
Male/Female 48/16
Left/Right 34/30
Height (cm)* 172 (10)
Weight (Kg)* 80 (17)
Management (Op/Non-Op) 19/45
*Data are means (SD)
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Responsiveness
Table 5 illustrates the percentage of reported responses
at the top (ceiling) of the total possible scores for the
ATRS, DRI and EQ 5D and the percentage of reported
responses at the bottom (floor) of the possible score for
the ATRS, DRI and EQ5D. All three scores demon-
strated a ceiling effect (defined as > 15% respondents)
for reported pre-injury scores, which was highest for the
more generic quality of life measure, EQ 5D. The ATRS
and DRI scores did not demonstrate a ceiling effect at
any other time point. This was in contrast to the EQ
5D, which demonstrated further ceiling effects at the six
and nine moth time points. None of the three outcome
measures demonstrated any floor effects.
Table 6 shows the relative efficiency of the ATRS in
relation to the EQ 5D and DRI at each time point. On
all occasions the ATRS demonstrated greater respon-
siveness when compared to the DRI and EQ 5D. At the
six month time point the ATRS was 2.1 times more
responsive EQ 5D and at nine months it was four times
more responsive. The same trends were evident when
compared to the DRI, but to a lesser extent, with the
ATRS being 1.3 times more responsive at six months
and 2.7 times more responsive at nine months.
Discussion
The ATRS was published in 2007, and advocated by the
authors as the only validated PROM available to evaluate
patients following a rupture of their Achilles tendon [10].
There have been no subsequent validation studies. There-
fore, this study represents the first paper to investigate
aspects of validity, outside of the developing centre.
We investigated aspects of internal consistency, con-
vergent validity and responsiveness of the ATRS, using a
sample of 64 patients. The ATRS was found to have high
internal consistency at each time point (Cronbach’s alpha
between 0.89 and 0.95). This finding is also consistent
with the original development article, which reported a
Cronbach’s alpha of 0.96. However, a result above 0.90
has been debated within the literature as being an indica-
tion that the outcome is too homogeneous [19,20]. The
implication being that further item reduction may be
appropriate [1].
Convergent validity of the ATRS was evaluated against
the DRI score. Correlation coefficients between the DRI
and ATRS demonstrated statistically significant correla-
tions between the two scores at each time point. How-
ever the confidence intervals around this were wide,
with only the six and nine month time points demon-
strating a correlation coefficient of at least 0.7. These
wide confidence intervals may be the result of the lim-
ited sample size of this study. Alternatively, they may
reflect an element of heterogeneity amongst the sample.
For example the inclusion of patients managed both
Table 2 Overall ATRS, DRI and EQ-5D scores at each time point
Time Point ATRS: All Patients DRI: All Patients EQ-5D: All Patients
n Min Max Mean SD Min Max Mean SD Min Max Mean SD
Pre-Injury 64 7 100 91 21 0 65 6 13 0.64 1.0 0.96 0.09
6 Weeks 63 5 88 35 19 0 81 41 17 0.12 1.0 0.7 0.19
3 Months 60 2 71 40 16 0 79 33 15 0.52 1.0 0.76 0.11
6 Months 58 15 100 66 23 0 72 16 14 0.43 1.0 0.87 0.14
9 Months 56 25 100 79 20 0 64 10 12 0.69 1.0 0.93 0.11
n ATRS: Non-Operative DRI: Non-Operative EQ-5D: Non-Operative
Pre-Injury 45 7 100 91 23 0 65 5 14 0.64 1.0 1 0.10
6 Weeks 44 5 78 33 17 0 81 43 18 0.28 1.0 0.70 0.2
3 Months 42 2 71 40 16 0 79 33 16 0.52 1.0 0.70 0.1
6 Months 40 15 100 65 23 0 72 17 16 0.43 1.0 0.90 0.20
9 Months 38 25 100 78 20 0 64 12 13 0.69 1.0 0.90 0.10
n ATRS: Operative DRI: Operative EQ-5D: Operative
Pre-Injury 19 31 100 91 18 0 31 8 11 0.73 1.0 0.9 0.10
6 Weeks 19 8 88 40 21 19 65 36 11 0.12 1.0 0.7 0.2
3 Months 18 20 69 40 14 10 48 32 12 0.56 1.0 0.8 0.1
6 Months 18 25 100 68 24 0 32 13 11 0.69 1.0 0.9 0.1
9 Months 18 39 100 81 20 0 26 7 7 0.69 1.0 0.9 0.10
Table 3 Cronbach’s alpha for the ATRS at each time point
Time Point Cronbach’s alpha
Pre-Injury 0.98
6 Weeks 0.89
3 Months 0.89
6 Months 0.95
9 Months 0.94
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Table 4 Convergent validity
Time Point EQ-5D Mobility Sub-Division EQ-5D Usual Activity Sub-Division EQ-5D DRI DRI (1) DRI (2) DRI (3)
Pre-Injury Correlation coefficient -0.4
(-0.60 to -0.06)
-0.4
(-0.60 to -0.22)
0.4
(0.65 to 0.20)
-0.6
(-0.78 to -0.30)
-0.5
(-0.74 to -0.25)
-0.5
(-0.71 to -0.21)
-0.6
(-0.80 to -0.40)
Significance 0.004 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
6 Week Correlation coefficient -0.5
(-0.64 to -0.23)
-0.3
(-0.51 to -0.07)
0.5
(0.69 to 0.33)
-0.5
(-0.68 to -0.28)
-0.5
(-0.68 to -0.33)
-0.3
(-0.50 to -0.04)
-0.3
(-0.59 to -0.13)
Significance < 0.001 0.019 < 0.001 < 0.001 < 0.001 0.010 0.010
3 Month Correlation coefficient -0.5
(-0.74 to -0.35)
-0.2
(-0.49 to 0.44)
0.6
(0.75 to 0.32)
-0.5
(-0.76 to -0.37)
-0.5
(-0.74 to -0.28)
-0.5
(-0.72 to -0.24)
-0.3
(-0.55 to 0.2)
Significance < 0.001 0.100 < 0.001 < 0.001 < 0.001 < 0.001 0.020
6 Month Correlation coefficient -0.5
(-0.70 to -0.35)
-0.6
(-0.71 to -0.26)
0.5
(0.70 to 0.21)
-0.7
(-0.80 to -0.36)
-0.5
(-0.73 to -0.24)
-0.7
(-0.85 to -0.45)
-0.6
(-0.78 to -0.41)
Significance < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
9 Month Correlation coefficient -0.4
(-0.61 to -0.24)
-0.5
(-0.65 to -0.18)
0.3
(0.51 to 0.01)
-0.9
(-0.94 to -0.83)
-0.4
(-0.64 to -0.4)
-0.9
(-0.92 to -0.8)
-0.8
(-0.90 to -0.68)
Significance 0.001 < 0.001 0.020 < 0.001 0.010 < 0.001 < 0.001
Data are Spearman Rank correlation coefficient (95% Confidence Intervals)
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operatively and non-operatively and patients with co-
morbidities such as asthma or diabetes, may affect the
distribution of PROMs scores.
These results do however provide some evidence that
the ATRS is measuring similar aspects of outcome when
compared to the DRI. The main limitation with this meth-
odology was highlighted by the developing authors of the
score, who acknowledged that this element of validity
should be interpreted with caution as there was no exist-
ing gold-standard PROM with which to compare.
Further exploring correlations of the ATRS with the
DRI we next investigated if the ATRS correlated more
strongly with aspects of the three DRI sub-divisions. To
further analyse aspects of convergent validity the ATRS
was also correlated against the EQ-5D and two of its sub-
divisions evaluating ‘mobility’ and ‘usual activities’. Again
the confidence intervals were large across the time points
and scales evaluated. There size of the correlations did
not fulfil the pre-defined criteria of 0.7 within the EQ-5D
or its subdivisions. Within the DRI this criteria was met
by the second and third sub-divisions of the DRI at the
six and nine month time points. These results were
anticipated by the authors to an extent because the EQ-
5D measures more generic quality of life, as opposed to
the alternative construct of physical activity, measured by
the ATRS. Again the key limitation of these correlations
is that the three scores are measuring only similar
constructs as opposed to exact constructs and with the
large confidence intervals reported, a larger sample may
be required. A ‘foot and ankle’ specific PROM may pro-
vide a more exact construct for comparison, but as
described in the methods section there is also a distinct
lack of robustly-developed outcome measures in this area
[14].
The more specific ATRS outcome measure demon-
strated greater responsiveness than the more generic DRI
and EQ-5D scores at each time point. These results were
in keeping with the original development article. The level
of responsiveness was only marginal in comparison to the
DRI and EQ-5D up until the three month time point, with
greater levels of responsiveness evident at the six month
and nine month time points. This may by representative
of the greater ceiling effects seen within the EQ-5D and
DRI scores. There are many methods available to deter-
mine responsiveness. This method was used as opposed to
more routinely reported effect sizes because it does not
require parametric assumptions.
Conclusion
This study provides further evidence regarding the valid-
ity of a newly developed measurement tool. Overall the
ATRS demonstrated high internal consistency and
responsiveness in comparison to the EQ-5D and DRI. It
has also demonstrated minimal ceiling effects (within
pre-injury scores only), and no floor effects. There was
limited evidence of convergent validity with the DRI and
EQ5D, although these tools do measure slightly different
constructs. The descriptive data in Table 2 will provide
researchers with a useful resource of estimates of range
and spread of scores across multiple time points, but
further research will be required to determine minimally
important differences within this score.
Future areas of research could explore the use of this tool
in the separate operative and non-operative populations,
and within patients with chronic rupture presentations.
Table 6 Relative efficiency of the ATRS across all time points
Time
Point
ATRS: Z statistic derived
from Wilcoxon sign rank
test
EQ-5D: Z statistic derived
from Wilcoxon sign rank
test
DRI: Z statistic derived
from Wilcoxon sign rank
test
Relative Efficiency
ATRS versus EQ-5D
Relative Efficiency
ATRS versus DRI
Pre-
Injury/6
Week
-6.8 -6.5 -6.7 (-6.8/-6.5)2 = 1.1 (-6.8/-6.7)2 = 1.0
Pre
Injury/3
Month
-6.7 -6.3 -6.2 (-6.7/-6.3)2 = 1.1 (-6.7/-6.2)2 = 1.2
Pre
Injury/6
Month
-5.5 -4.3 -4.8 (-5.5/-4.3)2 = 2.1 (-5.5/-4.8)2 = 1.3
Pre
Injury/9
Month
-4.6 -2.3 -2.8 (-4.6/-2.3)2 = 4 (-4.6/-2.8)2 = 2.7
Table 5 Percentage of ATRS, EQ-5D and DRI respondents
at either the floor or ceiling of the score
Time Point % Ceiling % Floor
ATRS EQ-5D DRI ATRS EQ-5D DRI
Pre-Injury 58% 81% 47% 0% 0% 0%
6 Weeks 0% 6% 3% 0% 0% 0%
3 Months 0% 8% 0% 0% 0% 0%
6 Months 4% 58% 9% 0% 0% 0%
9 Months 11% 66% 14% 0% 0% 0%
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While there is certainly scope to further explore aspects of
validity of this new score, ideally with even larger samples,
this study is a positive step towards the use of a universal
measure of outcome for patients with a rupture of the
Achilles tendon.
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